SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Atox Bio Raises $3.25 Million to Advance Development of AB103, a Novel Therapy for the Treatment of Severe Bacterial Infections, Currently in Phase 2 Clinical Trials